Bayer AG (BAYN) PT Set at €130.00 by Citigroup Inc.
Bayer AG (FRA:BAYN) has been assigned a €130.00 ($152.94) price target by investment analysts at Citigroup Inc. in a research report issued to clients and investors on Thursday. The firm currently has a “buy” rating on the healthcare company’s stock.
Several other research analysts also recently commented on the company. Warburg Research set a €121.00 ($142.35) price objective on Bayer AG and gave the stock a “neutral” rating in a report on Thursday. Independent Research GmbH set a €120.00 ($141.18) price target on Bayer AG and gave the company a “neutral” rating in a report on Wednesday. Baader Bank set a €140.00 ($164.71) price target on Bayer AG and gave the company a “buy” rating in a report on Thursday, September 28th. BNP Paribas set a €130.00 ($152.94) price target on Bayer AG and gave the company a “buy” rating in a report on Monday, September 25th. Finally, Jefferies Group LLC set a €132.00 ($155.29) price target on Bayer AG and gave the company a “buy” rating in a report on Monday, September 18th. Eight equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of €121.55 ($142.99).
Shares of Bayer AG (FRA:BAYN) traded down 0.66% during midday trading on Thursday, reaching €116.55. The company had a trading volume of 7,367 shares. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.82. The stock has a market capitalization of €101.64 billion and a price-to-earnings ratio of 20.16. The firm’s 50 day moving average price is €110.06 and its 200-day moving average price is €111.84.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.